The focus of centralized procurement in 2022: no less than 100 drugs in each province, including Chinese patent medicine, orthopedics, oral cavity, and balloon

The National Medical Insurance Bureau has clarified that by the end of 2022, the number of drug varieties collected by provinces (including inter-provincial alliances) should not be less than 100, and must include chemical drugs, proprietary Chinese medicines, orthopedic trauma, oral implants, drug balloons and other consumables
.
In 2022, it is planned to focus on the centralized procurement of two alliances, the Chinese patent medicine alliance led by Hubei and the oral implant alliance led by Sichuan
.
In the future, centralized procurement will become the basic model of public hospitals
.
In order to implement the requirements of the executive meeting of the State Council on "speeding up and expanding coverage" for centralized procurement with volume, the National Medical Insurance Administration recently made a unified deployment and coordination for the centralized procurement of local alliances
.
The first is to benchmark the tasks and implement them one by one
.
It is clarified that by the end of 2022, the provinces (including inter-provincial alliances) will carry out their own centralized procurement of no less than 100 varieties of drugs, which must include chemical drugs, Chinese patent medicines, orthopedic trauma, oral implants, drug balloons, etc.
consumables
.
The second is to strengthen overall planning and highlight key points
.
For key varieties, according to the leading intentions and capabilities of the provinces, the leading provinces of the corresponding varieties are identified, and other provinces with intention to join are encouraged to join in, expand the scope of the alliance, and optimize the frequency and rhythm of centralized procurement
.
The third is to strengthen expectation management
.
Identifying key inter-provincial alliances this year in advance will help enhance the industry's predictability of centralized procurement policies, facilitate companies to plan market strategies and production arrangements in advance, reduce uncertainty, and stabilize market expectations
.
According to the work arrangement, the centralized procurement of the alliance to be promoted in 2022 includes: Hubei-led Chinese patent medicine alliance procurement, Sichuan-led oral implant alliance procurement, these two alliances are expected to participate in most provinces
.
At the same time, Fujian will lead the procurement alliance for electrophysiology and endoscopic staplers, Shandong will lead the procurement alliance for Chinese herbal pieces, Guangdong will lead the procurement alliance for new crown-related testing reagents and consumables, and Jiangxi will lead the procurement alliance for liver function biochemical reagents.
A considerable number of provinces will participate
.
In addition, existing alliances such as the "Eight Provinces and Two Districts" procurement alliance and the Guangdong-led drug procurement alliance will continue to expand the coverage of varieties.
Carry out alliance procurement and encourage provinces to participate independently
.
In 2022, strive to achieve more than 100 varieties of provincial-level centralized procurement in each province, and cover 5 varieties of high-value medical consumables Mr.
Chen Jinfu, deputy director of the National Medical Insurance, said that from the perspective of the situation in the past three years, including local centralized procurement, the average number of centralized procurement varieties in each province has reached 50, and the number of high-value medical consumables has reached 3
.
In 2022, local governments will be guided to carry out inspections and filling gaps based on large varieties and common diseases according to clinical needs, and strive to achieve more than 100 provincial-level centralized collection varieties in each province, and high-value medical consumables can cover 5 varieties
.
At the same time, the coverage of centralized procurement will be further expanded
.
This year, in accordance with the principle of "one product, one policy", we will carry out centralized procurement of high-value medical consumables for the consumables that have received much feedback from the masses and have large room for price adjustment
.
In the local area, further exploration in other areas
.
Including proprietary Chinese medicines, on the basis that some provinces have organized alliance procurement last year, the scope will be further expanded in an orderly manner this year
.
In this way, the three major fields are fully covered, and there is no living space for lucky sales
.
In addition, for the varieties that have already been collected, the follow-up and coordination of other provinces should be gradually implemented, so that the coverage can be quickly expanded to other regions
.
There are 23 inter-provincial alliances for centralized procurement of medicines and 18 alliances for centralized procurement of consumables.
According to the previous goal of the Medical Insurance Bureau, by the end of 2022, the total number of national and provincial centralized procurement of drugs will reach more than 350 in each province, a high value.
The number of types of medical consumables has reached more than 5, making centralized procurement the norm and stabilizing social expectations
.
At present, the national centralized procurement has carried out six batches and seven rounds, and the seventh batch of national centralized procurement has also started the information reporting work, involving a total of 59 drugs and 208 specifications
.
However, due to the epidemic, industry insiders expect the official launch time to be slightly delayed
.
In terms of the centralized procurement of provincial alliances, according to the statistics of the pharmaceutical studio, there are currently 23 inter-provincial alliances that carry out centralized drug procurement.
30 provinces (autonomous regions and municipalities) and the Xinjiang Construction Corps have joined different alliances.
For example, Qinghai has participated in 14 alliances.
There are 13 alliances in Hainan, Shanxi and Ningxia
.
Just this year, the two major Chinese patent medicine alliances, Guangdong Alliance and Hubei Alliance, covering more than half of China, have settled down, and the special centralized procurement of Chinese patent medicines has officially entered the substantive start-up stage from the level of discussion and preparation
.
Although the rules for the centralized procurement of Chinese patent medicines in the two alliances are different, it is not difficult to see that compared with the national procurement, the local centralized procurement rules are more sophisticated and complicated, and there are volume parts, stepped quotations, and dynamic supply.
, surplus allocation, incremental management, peak shaving, valley filling, low-price revival and other dynamic comprehensive management and control measures, the stock game is more obvious and intense than national mining
.
At present, the procurement of Hubei Chinese Patent Medicine Alliance has entered the stage of allocating procurement volume
.
According to public data, more than 24,000 medical institutions in 19 provinces participated in the centralized procurement of the alliance.
A total of 157 companies and 182 products from 17 product groups in the final procurement catalog participated in the quotation, with a procurement scale of nearly 10 billion yuan
.
In the end, 97 companies and 111 products were selected, and the selection rate was 62%.
The average price dropped by 42.
27%, and the largest drop was 82.
63%
.
The results of the proposed selection/alternative for the centralized procurement of the Guangdong Chinese Patent Medicine Alliance were also announced on April 8.
In the end, 361 varieties of 174 companies were to be selected/alternative, of which 249 varieties of 124 companies were to be selected for selection, and 112 of 56 companies were selected.
Variety to be selected
.
Judging from the data from the live broadcast of the bid opening, there are 663 products that can be quoted in this centralized procurement, 313 entrepreneurs can be quoted, and finally 576 products and 275 companies completed the quotation
.
From the perspective of completion rate, 87.
86% of enterprises participated, and 86.
88% of products generated quotations
.
With the continuous breakthroughs in the reform of the pharmaceutical field, consumables have also followed the pace of reform.
Up to now, 18 inter-provincial alliances have carried out centralized procurement of consumables
.
Although the varieties included in centralized procurement are not as diverse as drugs, with the increasing number of alliance areas, there will be fragmentation of centralized procurement projects similar to centralized drug procurement.
At the same time, it is foreseeable that more provinces and cities will participate in the future.
come from an alliance
.
As for the centralized procurement of dental implants that the industry is concerned about, the National Medical Insurance Bureau has previously revealed that it will be deployed from the beginning of 2021.
Sichuan will organize an inter-provincial alliance to study the procedures for the centralized procurement of dental implants.
At present, the plan is basically mature
.
On November 18 last year, Sichuan Province issued the "Notice on Carrying out the Information Collection of Some High-value Oral Medical Consumables Products", which officially started the information declaration for the maintenance of oral implants and repairing abutment medical consumables products.
I believe that soon The collection mode will be officially opened
.